632 results on '"Barnett, Brian"'
Search Results
2. Practical considerations in the establishment of psychedelic research programs
3. Psychotherapeutic Interventions in Clinical Trials of Psychedelics for the Treatment of Alcohol Use Disorder
4. Preexisting Psychiatric Conditions as Risk Factors for Diagnosed Long COVID-19 Syndrome Within Aggregated Electronic Health Record Data
5. Pre-Existing Psychiatric Conditions as Risk Factors for Diagnosed Long COVID-19 Syndrome within Aggregated Electronic Health Record Data
6. Race, economic status, and disparities in the receipt of benzodiazepine prescriptions in a large primary care sample
7. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature
8. The State of the Catatonia Literature: Employing Bibliometric Analysis of Articles From 1965–2020 to Identify Current Research Gaps
9. Reported firearm access among patients admitted to a dual diagnosis medically-assisted withdrawal unit over five years
10. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer
11. LSD use in the United States: Examining user demographics and their evolution from 2015–2019.
12. Microglial Density Alters Measures of Axonal Integrity and Structural Connectivity
13. Establishing an Agenda for Public Budgeting and Finance Research
14. Computerized Adaptive Testing (CAT) and the Future of Measurement-Based Mental Health Care
15. The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey.
16. Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.
17. Comment on egusphere-2023-2414
18. Quantitative diffusion imaging and genotype‐by‐sex interactions in a rat model of Alexander disease
19. The Zero Suicide Model in Addiction Treatment Settings: Recognizing the Need for Feasibility and Implementation Data
20. Scaling Up Point-of-Care Fentanyl Testing — A Step Forward
21. Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
22. American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey
23. Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States
24. Qualitative analysis of a psychological supportive counseling group for burn survivors and families in Malawi
25. Higher-Order Defeat in Realist Moral Epistemology
26. An Analysis of Benzodiazepine Prescribing to Primary Care Patients in a Large Healthcare System from 2019-2020.
27. Formulary Coverage of Esketamine and Ketamine for Depression in Ohio Health Insurance Marketplace and Medicaid Plans.
28. Quantitative diffusion imaging and genotype‐by‐sex interactions in a rat model of Alexander disease.
29. A Survey of American Psychiatrists Concerning Medication Prior Authorization Requirements
30. Factors associated with long length of stay in an inpatient psychiatric unit in Lilongwe, Malawi
31. Creativity and Spirituality.
32. Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD
33. Phencyclidine Positivity on Urine Drug Screening in Patients Treated for Alcohol Withdrawal on a Dual-diagnosis Medically Assisted Withdrawal Unit
34. Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry
35. An Expert Roundtable Discussion on the Use of Classic Monoamine Oxidase Inhibitors in the Treatment of Depression – Part One
36. Attenuation of severe ketamine-induced neuropsychiatric side effects by lamotrigine in a patient with treatment resistant bipolar depression: a case report
37. Monoamine Oxidase Inhibitors and Clinically Relevant Drug Interactions: A Guide for Preventing Serotonin Toxicity and Hypertensive Reactions
38. An Expert Roundtable Discussion on the Use of Classic Monoamine Oxidase Inhibitors in the Treatment of Depression – Part Two
39. Do rhythms exist in elbow flexor torque, oral temperature and muscle thickness during normal waking hours?
40. Integrated surface - ground water interaction approaches that can account for water quantity and quality transport
41. List of Contributors
42. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
43. A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs
44. Development and validation of a novel instrument to capture companion dog mortality data: the Dog Aging Project End of Life Survey
45. Perceived risk of LSD use in the United States from 2015-2019: Are Americans assessing LSD’s risk profile more favorably?
46. Abstract 1525: A novel platform for protein engineering and modification to expand the therapeutic index of anti-tumor therapeutics
47. Supplementary Data from IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
48. Supplementary Table 2 from IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
49. Supplementary Table 1 from IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
50. An Analysis of Benzodiazepine Prescribing to Primary Care Patients in a Large Healthcare System from 2019-2020
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.